Colorado Becomes First State to Limit Price of a Specific Drug
By Marissa Ventrelli | Colorado Politics
Colorado became the first state in the nation to set a price cap on a specific medication last week, following a unanimous decision by the Prescription Drug Affordability Review Board to limit the cost of a drug used to treat inflammatory conditions.
On Oct. 3, the board voted to set an Upper Payment Limit, or UPL, of $600 per 50mg unit of Enbrel, an injectable medication used to treat conditions like rheumatoid arthritis, ankylosing spondylitis, and plaque psoriasis. That comes out to about $30,000 a year, more than $20,000 less than the average insurance plan paid for the drug per person in 2023, according to the Colorado Consumer Health Initiative.
“This decision is a victory for hardworking Colorado families who have been stretched thin...

![FD863768-0ACF-495E-9D21-2EF784DFFA6B[1]](https://rockymountainvoice.com/wp-content/uploads/2026/06/FD863768-0ACF-495E-9D21-2EF784DFFA6B1-300x300.png)